请输入关键词查询对齐语料

  1. 输入关键词后点击检索按钮可查询指定关键词在语料中的对应情况
  2. 选择语种可限定关键词的语言，当前支持中文和英文，默认选择中文
  3. 主题选项中可限定检索语料的文章主题范围，默认全部主题
  4. 主题选项中可限定检索语料的文本类型范围，默认全部类型
  5. 在结果列表中，点击操作栏中的“查看中文全文”或“查看英文全文”按钮可查看该句所在的中文语料全文
句对齐列表 共 16269 个结果  
序号 中文 英文 操作
6901 2023年将纪念世卫组织成立75周年，为此，本次电影征集活动也特别向历史电影以及近期的学生电影开放，让学生们分享他们对当前挑战和未来改善健康的解决方案的看法。 In honour of WHO’s 75th anniversary in 2023, this call for films is also exceptionally open to historical films and to recent films by students sharing their vision about current challenges and  future solutions to improve health.
6902 将创建一个特殊的播放列表来突出这些内容。 A special playlist will be created to highlight these testimonies.
6903 在COVID-19技术获取池（C-TAP）计划下新签署的协议有助于改善全球获取COVID-19检测技术的机会 New agreement under C-TAP aims to improve global access to COVID-19 testing technologies
6904 2022年6月16日 | 新闻稿 | 日内瓦 16 June 2022 | News release
6905 药品专利池（MPP）代表COVID-19技术获取池（C-TAP）与非洲生物技术公司（南非制药公司）签署了一项新的公开、透明的分许可协议，以加速全球生产和销售COVID-19血清抗体技术产品。 A new, open, transparent sublicence agreement between the Medicines Patent Pool (MPP) on behalf of C-TAP, and South African pharmaceutical company Biotech Africa will accelerate the manufacture and sale of a COVID-19 serological antibody technology around the world.
6906 这是在世卫组织COVID-19技术获取池计划下签署的第一项分许可，世卫组织对此表示欢迎。 The World Health Organization welcomes the sublicence agreement, the first of its kind to be signed under the auspices of the WHO’s COVID-19 Technology Access Pool (C-TAP) initiative.
6907 世卫组织COVID-19技术获取池创立于2020年，用于促进以负担得起的方式及时公平地获得COVID-19卫生产品。 C-TAP was set up in 2020 to facilitate the timely, equitable and affordable access to COVID-19 health products.
6908 新协议参照了世卫组织和药品专利池去年与西班牙国家研究理事会（CSIC）达成的许可协议。 The new agreement builds on a licensing agreement announced by WHO and MPP last year with Spain’s National Research Council (CSIC).
6909 根据这一新的非排他性分许可协议，非洲生物技术公司可以生产并在全球各地推销西班牙国家研究理事会发明的COVID-19血清检测试剂。 The non-exclusive sublicence allows Biotech to manufacture and commercialize CSIC’s COVID-19 serological test worldwide.
6910 世卫组织总干事谭德塞博士指出，“不断检测是战胜COVID-19的最有效方法。 “The most effective way to get – and keep – ahead of COVID-19 is to keep testing,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General.